BiotechTube
Home/Aisa Pharma/Andrew Sternlicht
AS

Andrew Sternlicht

CEO and Founder

Aisa Pharma

Therapeutic Areas

Rare DiseasesAutoimmune DiseasesVascular Diseases

Aisa Pharma Pipeline

DrugIndicationPhase
AISA-021Raynaud's Phenomenon in Systemic Sclerosis (Scleroderma)Phase 2